National Center For Tuberculosis And Lung Diseases 1

1. Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022
2. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
3. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
4. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
1